Urokinase-induced smooth muscle cell responses require distinct signaling pathways: A role for the epidermal growth factor receptor

Medicine & Life Sciences

• Plasminogen Activators 100%
• Urokinase-Type Plasminogen Activator 96%
• ErbB Receptors 80%
• Smooth Muscle Myocytes 74%
• Mitogen-Activated Protein Kinase 3 52%
• Mitogen-Activated Protein Kinase 1 50%
• Phosphatidylinositols 30%
• Cell Movement 27%
• 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 26%
• Phosphotransferases 26%
• Cell Proliferation 22%
• SB 203580 21%
• Plasminogen Activator Inhibitor 1 12%
• Receptor Protein-Tyrosine Kinases 12%
• Phosphorylation 11%
• Transcriptional Activation 10%
• MAP Kinase Kinase 6 10%
• manumycin 10%
• MAP Kinase Kinase 3 9%
• RTKI cpd 8%
• Aminocaproic Acid 8%
• Aprotinin 7%
• Antifibrinolytic Agents 7%
• Wortmannin 6%
• Fibrinolysin 6%
• Pertussis Toxin 6%
• Serine Proteases 6%
• DNA 6%
• Mitogen-Activated Protein Kinase Kinases 6%
• G-Protein-Coupled Receptors 5%
• Mitogen-Activated Protein Kinases 5%
• Vascular Smooth Muscle 5%
• Thymidine 5%